← Browse by Condition
Medical Condition

aortic valve stenosis

Total Trials
9
Recruiting Now
9
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for aortic valve stenosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — aortic valve stenosis Clinical Trials

How many clinical trials are currently recruiting for aortic valve stenosis?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for aortic valve stenosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for aortic valve stenosis?
aortic valve stenosis research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a aortic valve stenosis clinical trial?
Eligibility criteria for aortic valve stenosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Duk-Woo Park, MD 1 trial
EmStop Inc 1 trial
IHF GmbH - Institut für Herzinfarktforschung 1 trial
Niguarda Hospital 1 trial
HemoCept Inc. 1 trial

Recruiting Clinical Trials

NCT05672836 Phase 4
Recruiting
ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
Enrollment
1,040 pts
Location
South Korea
Sponsor
Duk-Woo Park, MD
View Trial →
NCT07276711
Recruiting
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
Enrollment
663 pts
Location
United States
Sponsor
EmStop Inc
View Trial →
NCT07215143
Recruiting
Observational Study to Collect Data of Patient Which Recieving a TAVI in TAVI Procedure
Enrollment
300 pts
Location
Germany
Sponsor
IHF GmbH - Institut für Herzin...
View Trial →
NCT06000943
Recruiting
Ischemic And Bleeding Risk Assessment After TAVR
Enrollment
2,500 pts
Location
Belgium, Chile, Czec...
Sponsor
Niguarda Hospital
View Trial →
NCT07205341
Recruiting
Detecting Changes in Arterial Blood Volume and Cardiac Efficiency
Enrollment
20 pts
Location
United States
Sponsor
HemoCept Inc.
View Trial →
NCT05015452
Recruiting
The Leipzig TAVI Registry
Enrollment
20,000 pts
Location
Germany
Sponsor
Helios Health Institute GmbH
View Trial →
NCT06493994
Recruiting
Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry
Enrollment
100 pts
Location
Germany
Sponsor
University of Luebeck
View Trial →
NCT06420830
Recruiting
Valve Performance of the SAPIEN 3 Ultra RESILIA Valve: A Prospective Registry With Central Echocardiography Analysis.
Enrollment
150 pts
Location
Canada
Sponsor
Institut universitaire de card...
View Trial →
NCT01805739
Recruiting
Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation
Enrollment
5,000 pts
Location
Germany
Sponsor
Klinik für Kardiologie, Pneumo...
View Trial →

Related Conditions

transcatheter aortic valve replacement (2) heart failure (1) aortic stenosis (1) aortic valve disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology